Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Domainzf-C2H2

ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

8.09e-046938110PF00096
DomainZnF_GATA

MTA2 TRPS1

1.19e-0312812SM00401
DomainZINC_FINGER_C2H2_2

ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

1.87e-037758110PS50157
DomainZnf_GATA

MTA2 TRPS1

1.88e-0315812IPR000679
DomainGATA

MTA2 TRPS1

1.88e-0315812PF00320
DomainZINC_FINGER_C2H2_1

ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

1.91e-037778110PS00028
DomainGATA_ZN_FINGER_1

MTA2 TRPS1

2.14e-0316812PS00344
DomainGATA_ZN_FINGER_2

MTA2 TRPS1

2.14e-0316812PS50114
DomainZnf_C2H2-like

ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

2.28e-037968110IPR015880
DomainZnf_C2H2

ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

2.47e-038058110IPR007087
DomainZnF_C2H2

ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

2.54e-038088110SM00355
Domain-

ZNF668 ZNF547 ZNF335 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

2.66e-036798193.30.160.60
DomainZnf_C2H2/integrase_DNA-bd

ZNF668 ZNF547 ZNF335 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

3.08e-03694819IPR013087
DomainKRAB

ZNF547 ZNF347 ZNF778 ZNF700 ZNF785 ZNF433

4.62e-03358816PS50805
DomainKRAB

ZNF547 ZNF347 ZNF778 ZNF700 ZNF785 ZNF433

4.62e-03358816PF01352
DomainKRAB

ZNF547 ZNF347 ZNF778 ZNF700 ZNF785 ZNF433

5.34e-03369816SM00349
DomainKRAB

ZNF547 ZNF347 ZNF778 ZNF700 ZNF785 ZNF433

5.41e-03370816IPR001909
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MTA2 HSPG2 FLNC VAC14 LRFN1 GBF1 ABL1 SUGP2 CASKIN1 ZNF335 PFAS TOR4A DOCK6 SPEN CEP170B

5.89e-081105841535748872
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

MTA2 FLNC SUGP2 RPS15 LARP1 PFAS ATIC UQCRC2 SPEN PCM1 TP53

5.05e-07653841122586326
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

KIDINS220 SQSTM1 ATG2B PFAS CEP170B PCM1 AXIN1

7.83e-0720984736779422
Pubmed

Human transcription factor protein interaction networks.

HSPG2 SUGP2 RBM33 SQSTM1 TRPS1 MRPS23 RPS15 LARP1 UQCRC2 FOXA1 SPEN PCM1 TP53 SORD MRPL2

1.54e-061429841535140242
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

SLF2 RBM33 SQSTM1 TPRN PFAS BSN SPEN CEP170B PCM1 TP53

1.59e-06588841038580884
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

MTA2 FLNC SUGP2 SQSTM1 LARP1 PFAS ATIC UQCRC2 PCM1

2.36e-0647784931300519
Pubmed

Insights into selective activation of p53 DNA binding by c-Abl.

ABL1 TP53

5.76e-06284215661746
Pubmed

Attenuated clinical and osteoclastic phenotypes of Paget's disease of bone linked to the p.Pro392Leu/SQSTM1 mutation by a rare variant in the DOCK6 gene.

SQSTM1 DOCK6

5.76e-06284235241069
Pubmed

Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

ABL1 TP53

5.76e-06284210629029
Pubmed

The effects of c-Abl mutation on developing B cell differentiation and survival.

ABL1 TP53

5.76e-06284219299624
Pubmed

AMPK β1 reduces tumor progression and improves survival in p53 null mice.

PRKAB1 TP53

5.76e-06284228544264
Pubmed

Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway.

ABL1 SQSTM1

5.76e-06284231789418
Pubmed

Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming.

SQSTM1 AXIN1

5.76e-06284234743698
Pubmed

p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.

ABL1 TP53

5.76e-06284216380437
Pubmed

Zinc finger protein Zfp335 controls early T-cell development and survival through β-selection-dependent and -independent mechanisms.

ZNF335 TP53

5.76e-06284235113015
Pubmed

c-Abl: activation and nuclear targets.

ABL1 TP53

5.76e-06284210713716
Pubmed

Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer.

FOXA1 TP53

5.76e-06284235768267
Pubmed

Abl1 deletion in gut stem cells suppresses p53 induction and promotes colitis-associated tumor formation.

ABL1 TP53

5.76e-06284232652042
Pubmed

Meiotic Knockdown and Complementation Reveals Essential Role of RAD51 in Mouse Spermatogenesis.

DMC1 TP53

5.76e-06284228178517
Pubmed

Understanding the impact of 1q21.1 copy number variant.

PRKAB1 CHD1L

5.76e-06284221824431
Pubmed

Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation.

UQCRC2 TP53

5.76e-06284230674441
Pubmed

Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers.

ABL1 TP53

5.76e-06284228661474
Pubmed

c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency.

ABL1 TP53

5.76e-06284210805805
Pubmed

The role of autophagy in cadmium-induced acute toxicity in glomerular mesangial cells and tracking polyubiquitination of cytoplasmic p53 as a biomarker.

SQSTM1 TP53

5.76e-06284235624155
Pubmed

Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage.

PSRC1 TP53

5.76e-06284218291097
Pubmed

Genetic disruption of Abl nuclear import reduces renal apoptosis in a mouse model of cisplatin-induced nephrotoxicity.

ABL1 TP53

5.76e-06284223660976
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

THAP4 COL24A1 ZNF668 GBF1 TPRN ZNF335 AMOTL1 TRPS1 PFAS TP53

6.45e-06689841036543142
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

FLNC GBF1 SUGP2 TRPS1 LARP1 RITA1 CHD1L MRPL3 FOXA1 SPEN TP53

6.90e-06857841125609649
Pubmed

Network organization of the human autophagy system.

MTA2 FLNC GBF1 SQSTM1 PRKAB1 ATG2B PFAS CEP170B

1.10e-0543784820562859
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

MTA2 SUGP2 SQSTM1 TPRN TRPS1 BICRAL STK39 RAB11FIP1 FOXA1 CEP170B PCM1 TP53

1.51e-051116841231753913
Pubmed

AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.

PRKAB1 TP53

1.73e-05384220861022
Pubmed

Involvement of c-Abl, p53 and the MAP kinase JNK in the cell death program initiated in A2E-laden ARPE-19 cells by exposure to blue light.

ABL1 TP53

1.73e-05384219052872
Pubmed

Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.

TP53 AXIN1

1.73e-05384215526030
Pubmed

Meiotic telomere distribution and Sertoli cell nuclear architecture are altered in Atm- and Atm-p53-deficient mice.

ABL1 TP53

1.73e-05384211003672
Pubmed

Deacetylation of p53 modulates its effect on cell growth and apoptosis.

MTA2 TP53

1.73e-05384211099047
Pubmed

p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.

SQSTM1 TP53

1.73e-05384228512249
Pubmed

Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress.

ABL1 TP53

1.73e-05384218490454
Pubmed

Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.

ABL1 TP53

1.73e-05384212110584
Pubmed

Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53.

SQSTM1 TP53

1.73e-05384216793543
Pubmed

Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.

TP53 AXIN1

1.73e-05384232213661
Pubmed

p53 Protein interacts specifically with the meiosis-specific mammalian RecA-like protein DMC1 in meiosis.

DMC1 TP53

1.73e-05384214764457
Pubmed

Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3β and causes increased cell migration.

SLC39A9 TP53

1.73e-05384227654922
Pubmed

Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.

SQSTM1 TP53

1.73e-05384235439056
Pubmed

c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression.

ABL1 TP53

1.73e-05384227626309
Pubmed

The dual role of p62 in ferroptosis of glioblastoma according to p53 status.

SQSTM1 TP53

1.73e-05384235216629
Pubmed

FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations.

FOXA1 TP53

1.73e-05384235920317
Pubmed

Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.

PRKAB1 TP53

1.73e-05384219225536
Pubmed

Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90α Secretion.

RAB11FIP1 TP53

1.73e-05384232640214
Pubmed

Autophagy regulates apoptosis by targeting NOXA for degradation.

SQSTM1 TP53

1.73e-05384229758299
Pubmed

Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.

TRPS1 FOXA1

1.73e-05384226969828
Pubmed

Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint.

PTCRA TP53

1.73e-05384217555992
Pubmed

TRIM13 regulates ER stress induced autophagy and clonogenic ability of the cells.

SQSTM1 ZFYVE1

1.73e-05384222178386
Pubmed

Mouse DDA3 gene is a direct transcriptional target of p53 and p73.

PSRC1 TP53

1.73e-05384212082536
Pubmed

RAD51AP2 is required for efficient meiotic recombination between X and Y chromosomes.

DMC1 RAD51AP2

1.73e-05384235020426
Pubmed

Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.

ABL1 TP53

1.73e-05384227956626
Pubmed

Hyperthermia activates a subset of ataxia-telangiectasia mutated effectors independent of DNA strand breaks and heat shock protein 70 status.

ABL1 TP53

1.73e-05384217409407
Pubmed

Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics.

TP53 AXIN1

1.73e-05384215064706
Pubmed

c-Abl tyrosine kinase activates p21 transcription via interaction with p53.

ABL1 TP53

1.73e-05384217339230
Pubmed

Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway.

AMOTL1 TP53

1.73e-05384230531834
Pubmed

Autophagy gene FIP200 in neural progenitors non-cell autonomously controls differentiation by regulating microglia.

SQSTM1 TP53

1.73e-05384228634261
Pubmed

The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products.

ABL1 TP53

1.73e-0538428612582
Pubmed

The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.

PRKAB1 TP53

1.73e-05384221907923
Pubmed

EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.

SQSTM1 ATG2B LARP1 ZFYVE1 TP53

3.28e-0515084532423001
Pubmed

Expression of BCL2, TP53, FOXA1, and GATA3 in pTa bladder cancer recurrence.

FOXA1 TP53

3.45e-05484238624056
Pubmed

RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.

RITA1 TP53

3.45e-05484225445601
Pubmed

Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta.

ABL1 TP53

3.45e-05484215289456
Pubmed

IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathway.

PRKAB1 TP53

3.45e-05484221573174
Pubmed

Nuclear accumulations of p53 and Mdm2 are accompanied by reductions in c-Abl and p300 in zinc-depleted human hepatoblastoma cells.

ABL1 TP53

3.45e-05484216636310
Pubmed

c-Abl phosphorylates Hdmx and regulates its interaction with p53.

ABL1 TP53

3.45e-05484219075013
Pubmed

Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia.

ABL1 SQSTM1

3.45e-05484236086954
Pubmed

The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells.

FOXA1 TP53

3.45e-05484225281925
Pubmed

p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation.

PSRC1 TP53

3.45e-05484218793611
Pubmed

Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylation.

TRPS1 TP53

3.45e-05484223772552
Pubmed

ZNF768 links oncogenic RAS to cellular senescence.

ZNF778 TP53

3.45e-05484234404770
Pubmed

Abl interconnects oncogenic Met and p53 core pathways in cancer cells.

ABL1 TP53

3.45e-05484221455220
Pubmed

ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer.

ZNF668 TP53

3.45e-05484221852383
Pubmed

Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy.

SQSTM1 TP53

3.45e-05484227031960
Pubmed

Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.

TP53 AXIN1

3.45e-05484220122174
Pubmed

MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity.

TP53 AXIN1

3.45e-05484223826318
Pubmed

Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents.

ABL1 TP53

3.45e-05484217992189
Pubmed

c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression.

ABL1 TP53

3.45e-05484222729085
Pubmed

Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusion.

ABL1 TP53

3.45e-05484226295305
Pubmed

A positive role for c-Abl in Atm and Atr activation in DNA damage response.

ABL1 TP53

3.45e-05484220798688
Pubmed

Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.

FOXA1 TP53

3.45e-05484224549642
Pubmed

RITA, a novel modulator of Notch signalling, acts via nuclear export of RBP-J.

RITA1 SPEN

3.45e-05484221102556
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

GBF1 ABL1 SLF2 SQSTM1 LARP1 RAB11FIP1 DOCK6 CEP170B PCM1 TP53

4.34e-05861841036931259
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

MTA2 SUGP2 AMOTL1 ATG2B LARP1 SPEN PCM1 TP53

5.58e-0554984838280479
Pubmed

Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.

ABL1 TP53

5.74e-05584222889954
Pubmed

Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.

PRKAB1 STK39

5.74e-05584224808538
Pubmed

Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processes.

SQSTM1 TP53

5.74e-05584225497209
Pubmed

Axin determines cell fate by controlling the p53 activation threshold after DNA damage.

TP53 AXIN1

5.74e-05584219731416
Pubmed

H2AFX and MDC1 promote maintenance of genomic integrity in male germ cells.

DMC1 TP53

5.74e-05584229437857
Pubmed

DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis.

ABL1 TP53

5.74e-05584218480060
Pubmed

A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy.

SQSTM1 TP53

5.74e-05584226330555
Pubmed

AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.

TP53 AXIN1

5.74e-05584221057547
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

FLNC GBF1 SUGP2 RBM33 SQSTM1 LARP1 UQCRC2 ZFYVE1 SPEN

6.40e-0572484936232890
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

MTA2 THAP4 SUGP2 RBM33 LARP1 BICRAL ATIC SPEN PCM1 TP53 SORD

6.96e-051103841134189442
Pubmed

Autophagosomal Content Profiling Reveals an LC3C-Dependent Piecemeal Mitophagy Pathway.

HSPG2 SQSTM1 PCM1

7.04e-053384329149599
Pubmed

The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination.

SQSTM1 TP53

8.59e-05684227528230
Pubmed

Loss of Ribosomal Protein Paralog Rpl22-like1 Blocks Lymphoid Development without Affecting Protein Synthesis.

PTCRA TP53

8.59e-05684235046107
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF668 ZNF547 ZNF335 TRPS1 ZNF347 ZNF575 ZNF778 ZNF700 ZNF785 ZNF433

1.52e-05718481028
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

MTA2 TRPS1

7.09e-041548282
GeneFamilyMitochondrial ribosomal proteins

MRPS23 MRPL3 MRPL2

1.21e-0379483646
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

RAB11FIP1 C2CD4C

4.10e-0336482823
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HSPG2 COL24A1 LRFN1 CPXM2 CCDC80 C2CD4C

1.52e-06188846b382d18fb09fb2869f3c151efa71540a7f5ed229
ToppCell3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC KCNN1 DOCK6 KLKB1 TNXB

1.92e-0517384585083b9ce20351dd69aa2327ad087b848b4307ff
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor

FLNC SPSB4 THSD1 C2CD4C TNXB

2.20e-05178845c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCellTCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9

VAC14 SQSTM1 MRPS23 ATIC MRPL2

2.26e-051798458c6a84602b079bd357c66244371eb23dd9384918
ToppCell5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HSPG2 CPXM2 ZNF700 TNXB ZNF785

2.32e-0518084540d4838a0ccb10d5e49266bc8a0037d27b75ccc2
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC THSD1 C2CD4C KLKB1 TNXB

2.51e-05183845764ea07621f77fbd13a877aed5806ae2b3dfb43e
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FLNC THSD1 C2CD4C KLKB1 TNXB

2.51e-0518384538a54216458ad57f356bb4ddf272e1af8036ddeb
ToppCellmetastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass

HSPG2 FLNC CPXM2 CCDC80 TNXB

2.64e-05185845506eee2c1b6e8acec3aa8b2c66868010006c4c14
ToppCell390C-Endothelial_cells-Endothelial-F_(Lymphatics)|390C / Donor, Lineage, Cell class and subclass (all cells)

FLNC SPSB4 THSD1 C2CD4C TNXB

2.85e-05188845aa69e3f44d506f5ef358a3374ac5160d847c858f
ToppCell390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|390C / Donor, Lineage, Cell class and subclass (all cells)

FLNC SPSB4 THSD1 C2CD4C TNXB

2.85e-051888451f40b959777d18ad88d239df8cca304f062ba04c
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HSPG2 FLNC CCDC80 THSD1 TNXB

2.85e-0518884526915db8863f4115b46a81982e187322e21600fd
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HSPG2 FLNC CCDC80 THSD1 TNXB

2.85e-051888453f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HSPG2 COL24A1 FLNC CCDC80 TNXB

2.85e-05188845bba6b273bd47dd0e27fde914e9e6fc9d76fd5176
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HSPG2 FLNC CCDC80 THSD1 TNXB

2.85e-0518884561ee7b152745164293d8a44ef91ee2393efbdca5
ToppCellwk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

FLNC CPXM2 THSD1 C2CD4C TNXB

3.08e-05191845d25ac3206fe205a100cfee26431ff32c14c1938f
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

NYAP2 PLCL2 SLC4A10 BSN CEP170B

3.08e-051918455d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCellEntopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32

NYAP2 PLCL2 SLC4A10 BSN CEP170B

3.08e-0519184573dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCelldroplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

HSPG2 FLNC CPXM2 CCDC80 TNXB

3.32e-051948455594f7437448cb4b37d2d100f44d30c4a367df26
ToppCellfacs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLNC CCDC80 STK39 FOXA1 TNXB

3.48e-051968452029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCellMesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class

HSPG2 CPXM2 QPRT CCDC80 TNXB

3.57e-05197845cb321836980e7b4efbb9284c6af7ccd34079d2be
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

COL24A1 KCNN1 CCDC80 BSN TNXB

3.65e-051988452dc0510846cbc296a300b8465e7be9b39f479852
ToppCellParenchyma_Control_(B.)-Stromal-TX-Mesothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

COL24A1 KCNN1 CCDC80 BSN TNXB

3.65e-05198845eb7e674d08a7aeb554c1e4797338280581b79989
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

COL24A1 KCNN1 CCDC80 BSN TNXB

3.65e-05198845364de83e30d842123fb92367f54b4bea57a47c84
ToppCellSepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class

DMC1 PTCRA ZNF778 PSRC1 PGBD2

3.74e-051998450df6cafb7f3b607cbe80b6f25b4fd62d421d01ee
ToppCellNS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CCDC80 RAB11FIP1 FOXA1 PCM1 SORD

3.83e-0520084564462a18afca3c1a8548a857924b8166058bf958
Diseaseomega-6 polyunsaturated fatty acid measurement

NYAP2 PTCRA ZNF335 TRPS1 DOCK6 PSRC1

1.64e-05197806EFO_0005680
Diseasecholesterol in medium HDL measurement

NYAP2 TRPS1 DOCK6 PSRC1

2.04e-0559804EFO_0021903
Diseasephospholipids in HDL measurement

NYAP2 TRPS1 DOCK6 PSRC1

2.32e-0561804EFO_0022293
Diseaseobsolete_red blood cell distribution width

NYAP2 ABL1 ZBED6 SQSTM1 PLCL2 UGT2B10 LARP1 STK39 DOCK6 ZFYVE1 TMEM40 AXIN1 SORD

6.43e-0513478013EFO_0005192
Diseasedrebrin-like protein measurement

NLRP12 KLKB1

7.22e-055802EFO_0020333
Diseasetriglyceride measurement, high density lipoprotein cholesterol measurement

NYAP2 GBF1 TRPS1 UGT2B10 DOCK6 PSRC1

1.03e-04274806EFO_0004530, EFO_0004612
Diseaserho GTPase-activating protein 30 measurement

NLRP12 KLKB1

1.51e-047802EFO_0802012
Diseasecoiled-coil domain-containing protein 80 measurement

CCDC80 KLKB1

2.01e-048802EFO_0020268
Diseasetestis-expressed sequence 29 protein measurement

NLRP12 KLKB1

2.01e-048802EFO_0802125
Diseaseesophagus squamous cell carcinoma (is_implicated_in)

FOXA1 SPEN TP53

2.51e-0445803DOID:3748 (is_implicated_in)
DiseaseHEPATOCELLULAR CARCINOMA

TP53 AXIN1

2.58e-049802114550
DiseaseAdult Hepatocellular Carcinoma

TP53 AXIN1

2.58e-049802C0279607
Diseasetumor necrosis factor receptor superfamily member 16 measurement

NLRP12 KLKB1

2.58e-049802EFO_0802168
DiseaseHepatocellular carcinoma

TP53 AXIN1

2.58e-049802cv:C2239176
DiseaseSmall Lymphocytic Lymphoma

RPS15 TP53

3.22e-0410802C0855095
DiseaseB-lymphoblastic leukemia/lymphoma (is_implicated_in)

ABL1 TP53

3.22e-0410802DOID:0080630 (is_implicated_in)
DiseaseB-CELL MALIGNANCY, LOW-GRADE

RPS15 TP53

3.22e-0410802C1868683
DiseaseDuctal Carcinoma

FOXA1 TP53

3.93e-0411802C1176475
Diseasehematocrit

DMC1 VAC14 NYAP2 TRPS1 PLCL2 RPS15 PFAS BSN ZFYVE1 TMEM40

4.00e-0410118010EFO_0004348
Diseasephospholipids in medium HDL measurement

TRPS1 DOCK6 PSRC1

4.55e-0455803EFO_0022295
Diseasefree cholesterol to total lipids in very large HDL percentage

NYAP2 TRPS1 DOCK6

4.55e-0455803EFO_0022288
DiseaseMyeloproliferative disease

ATG2B TP53

4.71e-0412802C0027022
Diseasetotal lipids in medium HDL measurement

TRPS1 DOCK6 PSRC1

5.32e-0458803EFO_0022310
Diseasefree cholesterol in medium HDL measurement

NYAP2 TRPS1 DOCK6

5.32e-0458803EFO_0022267
Diseasefree cholesterol in HDL measurement

NYAP2 TRPS1 DOCK6

6.17e-0461803EFO_0022264
Diseasetotal lipids in HDL measurement

NYAP2 TRPS1 DOCK6

6.78e-0463803EFO_0022307
Diseaseosteoporosis

STK39 AXIN1 HSP90AB3P

1.04e-0373803EFO_0003882
Diseasephospholipids in large HDL measurement

NYAP2 TRPS1 DOCK6

1.04e-0373803EFO_0022190
Diseasetotal lipids in large HDL

NYAP2 TRPS1 DOCK6

1.08e-0374803EFO_0022189
Diseasestem Cell Growth Factor beta measurement

C12orf42 ZNF700 KLKB1

1.13e-0375803EFO_0008292
Diseaselung non-small cell carcinoma (is_marker_for)

ABL1 FOXA1 TP53 AXIN1

1.17e-03169804DOID:3908 (is_marker_for)
Diseaseosteochondrodysplasia (is_implicated_in)

HSPG2 TRPS1

1.20e-0319802DOID:2256 (is_implicated_in)
Diseaseperipheral neuropathy, response to docetaxel trihydrate

VAC14 NYAP2

1.20e-0319802EFO_0003100, GO_1902519
Diseasefree cholesterol in large HDL measurement

NYAP2 TRPS1 DOCK6

1.31e-0379803EFO_0022157
DiseaseAdenocarcinoma of prostate

FOXA1 AXIN1

1.34e-0320802C0007112
Diseasecholesterol in large HDL measurement

NYAP2 TRPS1 DOCK6

1.36e-0380803EFO_0021900
Diseasecorneal resistance factor

COL24A1 ABL1 CCDC80 FOXA1 ZFYVE1 HSP90AB3P

1.43e-03451806EFO_0010067
DiseasePrecursor B-cell lymphoblastic leukemia

ABL1 TP53

1.47e-0321802C1292769
Diseasetriacylglycerol 58:9 measurement

GBF1 TNXB

1.62e-0322802EFO_0010443
Diseaselinoleic acid measurement

NYAP2 ZNF335 DOCK6 PSRC1

1.66e-03186804EFO_0006807
DiseaseHMG CoA reductase inhibitor use measurement

NYAP2 TRPS1 UGT2B10 DOCK6

1.76e-03189804EFO_0009932
Diseasesmoking cessation

NYAP2 CPXM2 RBM33 PLCL2 BSN

1.92e-03325805EFO_0004319
Diseasecolon adenocarcinoma (is_marker_for)

PFAS FOXA1

2.09e-0325802DOID:234 (is_marker_for)
DiseaseBone Diseases, Developmental

ABL1 TRPS1

2.44e-0327802C0005941
Diseasephospholipid measurement, intermediate density lipoprotein measurement

ZNF335 TRPS1 PSRC1

2.50e-0399803EFO_0004639, EFO_0008595
Diseaseoral squamous cell carcinoma (is_implicated_in)

ABL1 TP53

2.62e-0328802DOID:0050866 (is_implicated_in)
Diseaseopioid use disorder

GBF1 PLCL2 KCNN1

2.64e-03101803EFO_0010702

Protein segments in the cluster

PeptideGeneStartEntry
GITGMSHRARPHGIS

nan

71

Q8N976
HREVRGPVLGHTATG

B3GALT5-AS1

6

P59052
SSKGSGRHHILSAGP

GPR20

331

Q99678
GHGKSPDHRGRVSSL

AMOTL1

926

Q8IY63
LHRVGPGDDRHSTKS

CEP170B

326

Q9Y4F5
KPIGGHILAHASTTR

DMC1

286

Q14565
GIHACRRGGVTLGHK

SORD

161

Q00796
KEGSSRTHRPGGKHG

CCDC74B

136

Q96LY2
RGEHTVHVGPRGSVR

C2CD4C

296

Q8TF44
HTPTRHGRNTVCGGK

ATG2B

1586

Q96BY7
HATIRGSHGGRKVPL

CCDC80

26

Q76M96
HRGIKGLVRDSHGKG

CPXM2

641

Q8N436
LLRGGSHFPHGISRV

RAD51AP2

1106

Q09MP3
PGVKRTVTHRTNSGG

RBM33

961

Q96EV2
EGATRGTTEPHSRGH

MTA2

411

O94776
KRGGSLPVRHQTHGS

HSPG2

2376

P98160
HKRGGSLPSHHQTRG

HSPG2

2761

P98160
HVLGAGPHVKRGSNT

UQCRC2

291

P22695
EARPGRHGHSIKRAS

CASKIN1

741

Q8WXD9
HPGGDRTGNHTSRAK

LARP1

656

Q6PKG0
LGSHRLHPATETGGR

PTCRA

191

Q6ISU1
SHSGKRGIPHSLSGL

KIDINS220

1621

Q9ULH0
VHADHGEPIGRGTKV

HSP90AB3P

146

Q58FF7
TKRHRSTPHLDGAGG

LRFN1

726

Q9P244
RASGKPSNVGHRLGH

KCNN1

81

Q92952
KTGGTTSPKHGRAEH

BSN

431

Q9UPA5
GVGRRRTKTPHTFPH

PCM1

71

Q15154
ETGHHAPGLKLRGTG

LCTL

211

Q6UWM7
GGRHGSVSLLRHPGT

FAM218A

51

Q96MZ4
KVTGPRLSGGHSLHE

FLNC

2591

Q14315
TGHVAGTRKTTPGFR

QPRT

131

Q15274
GKEPGGSRAHSSHLK

TP53

356

P04637
AGHRVRESGHKVPVS

PSRC1

321

Q6PGN9
KERGHHGASSSREPV

NYAP2

561

Q9P242
DSPLHRGVHGKTGQL

FOXA1

306

P55317
GPEGHRKTSSRSDHG

BICRAL

936

Q6AI39
KGLLRAHGTHPAIST

DOCK6

306

Q96HP0
HRRTGHGSSGTRKPQ

AXIN1

646

O15169
ASVHLPRIGHATKGF

CHD1L

836

Q86WJ1
RRHKHSSESPGRDKG

ABL1

876

P00519
GSHTLLGAVGEPHRR

CYP26C1

126

Q6V0L0
HGRPGKIHRSATDAD

GBF1

1326

Q92538
TLPKVHRTGAVSGHS

KLKB1

86

P03952
HSHKPDATGGRGLSR

SLC39A9

271

Q9NUM3
HGQTKTHRRPGAVAT

MRPL3

231

P09001
GEARTQHGGSHVSRK

MRPS23

136

Q9Y3D9
ALSQHPHSRKGGLIG

VAC14

61

Q08AM6
GAGTGSAKHRLHPVK

RAB11FIP1

1166

Q6WKZ4
VHVAITNRRGGGKPH

PLCL2

876

Q9UPR0
HLRPGSTAHAAAGKR

SLF2

26

Q8IX21
GGLHSSRPLKRGLSH

RITA1

186

Q96K30
GKGLHRGHTKLAFPS

SQSTM1

156

Q13501
SERAALERHGGHKTP

PRKAB1

6

Q9Y478
EAQGIHISRHTRPKG

C12orf42

186

Q96LP6
HQLGLGGKDVRHSSP

COL24A1

46

Q17RW2
FGHRGSKQLHRGKPV

PGBD2

276

Q6P3X8
VKHGRPGIGATHSSR

RPS15

126

P62841
HLSPGAAGSSRVKHQ

TRPS1

601

Q9UHF7
SQLRVHGGTHTGEKP

ZNF700

431

Q9H0M5
CGLTRHVRTHTGEKP

ZNF778

406

Q96MU6
APELRSHGRSHTGEK

ZNF668

96

Q96K58
ERTGGSPSVRHGSFH

SPEN

1256

Q96T58
HRHPVAQSTDGIRGK

SPSB4

76

Q96A44
PSGHEGAAPGHTRRK

PFAS

11

O15067
RHVGSRGGPSERSHA

THSD1

631

Q9NS62
SKLATHRLAHGGARP

ZNF575

76

Q86XF7
GVHVPLGGRKSHRRH

SLC4A10

51

Q6U841
SGTRLKHHGRQAPGL

SUGP2

706

Q8IX01
GLHHGKRVGPISAVA

TNXB

1846

P22105
ATGKHRRSLGAGYPH

TMEM40

81

Q8WWA1
KSGGRDHTGRIRVHG

MRPL2

81

Q5T653
APGTRRHFSTSRGGH

nan

16

Q5XG85
LGGRVKTLHPAVHAG

ATIC

61

P31939
KHGGRVRTFPHERGN

USB1

66

Q9BQ65
RTHSGGNKRRHPVTV

ZFYVE1

106

Q9HBF4
SHLARHRRVHTGGKP

ZNF347

666

Q96SE7
ALHGPSGVGKSHVGR

TOR4A

191

Q9NXH8
SGVGKSHVGRLLARH

TOR4A

196

Q9NXH8
GKPGSHLGTSTLQRH

ZBED6

161

P86452
RAAGHRSHKRKLSGP

nan

241

Q8N9G6
GDGGRPTFVKNHRVH

ZNF547

136

Q8IVP9
GSNSFTVHPRGLHRG

TPRN

201

Q4KMQ1
LLGHPKTRAFITHGG

UGT2B10

361

P36537
AKKVRRVPGSSGHLH

STK39

361

Q9UEW8
HIQRLHSPDGRKSGT

ZNF335

1121

Q9H4Z2
SNLRRHGRTHTGEKP

ZNF433

631

Q8N7K0
HLTEKKRGAGGHGRT

THAP4

86

Q8WY91
GSLAIHRRAHTGEKP

ZNF785

241

A8K8V0
RGHARTVGHQASPIK

NLRP12

181

P59046